Intravitreal anti-VEGF treatment for subretinal neovascularisation secondary to type 2 idiopathic juxtafoveolar telangiectasia
Crossref DOI link: https://doi.org/10.1007/s10792-017-0447-0
Published Online: 2017-01-21
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Barth, Teresa http://orcid.org/0000-0001-9748-6171
Zeman, Florian
Helbig, Horst
Gamulescu, Maria-Andreea
License valid from 2017-01-21